JACC: Case Reports (Nov 2020)

Lenalidomide-Induced Myocarditis, Rare But Possibly Fatal Toxicity of a Commonly Used Immunotherapy

  • Robin Jacob, MD,
  • Paolo Strati, MD,
  • Nicolas Palaskas, MD,
  • Juan C. Lopez-Mattei, MD,
  • Konstantinos Marmagkiolis, MD,
  • L. Maximilian Buja, MD,
  • Anita Deswal, MD,
  • Cezar Iliescu, MD

Journal volume & issue
Vol. 2, no. 13
pp. 2095 – 2100

Abstract

Read online

A 66-year-old woman with follicular lymphoma on lenalidomide and rituximab presented with chest pain. High-sensitivity troponin T peaked at 7,566 ng/l. Cardiac biopsy revealed extensive inflammation consistent with medication-induced myocarditis. Lenalidomide was stopped with improvement in troponins and patient was initiated on high-dose corticosteroid therapy. (Level of Difficulty: Intermediate.)

Keywords